BioLife Solutions

Company

Investment-firm

Last deal

$10.4M

Amount

Post-IPO Equity

Stage

27.10.2023

Date

3

all rounds

$99.M

Total amount

General

About Company
BioLife Solutions is a company that provides biopreservation tools and services for cells, tissues, and organs.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Cryomedical Sciences, Trans Time Medical Products, Cryomedical Sciences Inc

founded date

01.01.1987

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Based in Bothell, Washington, BioLife Solutions designs, manufactures, and markets proprietary and generic biopreservation media products. They also offer contract research, consulting, and custom formulation services. Their goal is to maintain the health and function of biologic source material and finished products during manufacturing, distribution, and clinical administration, in order to facilitate research and the commercialization of new therapies.
Contacts